Rocket Lab USA, Inc.

NASDAQ:RKLB

17.83 (USD) • At close March 11, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 132.388104.808106.25192.76759.99167.66162.04554.89551.76263.05755.47440.70327.4785.28711.2818.19215.73710.677.3361.417
Cost of Revenue 95.57176.81282.03671.9244.49952.69447.45248.53849.93254.5950.51636.96820.79317.7388.81716.78119.79112.5559.5175.115
Gross Profit 36.81727.99624.21520.84715.49214.96714.5936.3571.838.4674.9583.7356.685-12.4512.4631.411-4.054-1.885-2.181-3.698
Gross Profit Ratio 0.2780.2670.2280.2250.2580.2210.2350.1160.0350.1340.0890.0920.243-2.3550.2180.078-0.258-0.177-0.297-2.61
Reseach & Development Expenses 48.25547.72338.8637.10137.48826.62631.03523.90515.01817.50819.16513.47711.96814.1898.5297.0788.1334.9033.1562.95
General & Administrative Expenses 00000028.71700018.952000000000
Selling & Marketing Expenses 00000000000000000000
SG&A 40.11132.17230.52426.82525.68227.228.71728.46924.03522.96118.95223.07819.04825.6557.0686.6246.6156.0575.8145.506
Other Expenses 000-0.5890.1961.1760.8661.4770.3850.622-0.0230.026-0.215-0.45-0.2420.109-0.43-0.0400
Operating Expenses 88.36679.89570.43663.92663.1753.82659.75252.37439.05340.46938.11736.55531.01639.84415.59713.70214.74810.966.56510.503
Operating Income -51.549-51.899-43.274-43.079-47.678-38.859-45.159-46.017-37.223-32.002-33.159-32.82-24.331-52.295-13.134-12.291-18.802-12.845-11.151-12.154
Operating Income Ratio -0.389-0.495-0.407-0.464-0.795-0.574-0.728-0.838-0.719-0.508-0.598-0.806-0.885-9.891-1.164-0.676-1.195-1.204-1.52-8.577
Total Other Income Expenses Net -0.1210.9040.783-1.176-1.603-0.3570.0310.926-0.995-0.915-6.33110.49920.986-37.358-3.091-3.327-0.453-0.762.408-1.807
Income Before Tax -51.67-50.995-42.491-44.255-49.486-39.216-45.128-45.091-38.218-32.917-39.49-22.321-3.345-89.653-16.225-15.618-18.229-13.605-8.743-13.961
Income Before Tax Ratio -0.39-0.487-0.4-0.477-0.825-0.58-0.727-0.821-0.738-0.522-0.712-0.548-0.122-16.957-1.438-0.859-1.158-1.275-1.192-9.853
Income Tax Expense 0.6750.944-0.860.0051.0111.3520.7610.526-1.011.693-2.0734.388-6.541-1.6840.440.2640.718-10.4630.286
Net Income -52.345-51.939-41.631-44.26-50.497-40.568-45.889-45.617-37.208-34.61-37.417-26.7093.196-87.969-16.665-15.882-18.947-12.605-9.206-14.247
Net Income Ratio -0.395-0.496-0.392-0.477-0.842-0.6-0.74-0.831-0.719-0.549-0.674-0.6560.116-16.639-1.477-0.873-1.204-1.181-1.255-10.054
EPS -0.11-0.1-0.084-0.09-0.1-0.084-0.096-0.096-0.079-0.074-0.081-0.0590.014-0.39-0.037-0.036-0.042-0.028-1.11-1.76
EPS Diluted -0.11-0.1-0.084-0.09-0.1-0.084-0.096-0.096-0.079-0.074-0.081-0.0590.014-0.39-0.037-0.036-0.042-0.028-1.11-1.76
EBITDA -40.753-42.446-34.024-35.508-39.753-31.067-38.407-36.54-39.026-24.149-25.51-12.613-21.877-84.113-10.684-9.894-14.837-12.154-8.817-10.825
EBITDA Ratio -0.308-0.405-0.32-0.38-0.659-0.442-0.618-0.683-0.712-0.382-0.46-0.987-1.632-2.989-0.969-0.362-1.071-1.139-1.202-7.639